Related Experiment Video
Updated: Jun 25, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
MDM2 and MDM4 splicing: an integral part of the cancer spliceome
Selvi Jeyaraj1, Dennis M O'Brien, Dawn S Chandler
1The Center for Childhood Cancer, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio 43205, USA.
Abstract:
MDM2 and MDM4, the murine double minute proteins, are oncogenes that function as important regulators of various proteins. One fundamental role for these proteins is regulation of the tumor suppressor, p53. Precise regulation of p53 is vital for coordinated malignant suppression and cell survival. Alternative splice forms of MDM2 as well as MDM4 have been associated with various cancers. Indeed, UV irradiation triggers alternative splicing of both MDM2 and MDM4. Coordinated alternative splicing in response to cellular stress or in cancerous cells regulates the posttranscriptional expression of these two genes and likely others. This concert of stress responsive mRNAs comprises the cancer spliceome and provides a fingerprint of coordinated alternative splicing in these aberrant cells. Although various transcripts have been described for both proteins, here we provide a precise catalog of the alternatively spliced transcripts of both genes and the cancers with which they are associated.
Insights
Murine double minute 2 (MDM2) and MDM4 proteins regulate tumor suppressor p53. Alternative splicing of MDM2 and MDM4 is linked to cancer, forming a cancer spliceome that aids in diagnosis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MDM2 and MDM4 are oncogenes regulating proteins, notably the tumor suppressor p53.
- Precise p53 regulation is crucial for preventing malignancy and ensuring cell survival.
- Alternative splicing of MDM2 and MDM4 is observed in various cancers.
Purpose of the Study:
- To catalog alternatively spliced transcripts of MDM2 and MDM4.
- To associate these splice variants with specific cancer types.
- To understand the role of coordinated alternative splicing in cancer.
Main Methods:
- Analysis of MDM2 and MDM4 gene transcripts.
- Identification of alternative splicing events.
- Correlation of splice variants with cancer patient data.
Main Results:
- A comprehensive catalog of MDM2 and MDM4 alternatively spliced transcripts was generated.
- Specific splice forms were linked to distinct cancer types.
- UV irradiation was shown to induce alternative splicing in both MDM2 and MDM4.
Conclusions:
- Coordinated alternative splicing of MDM2 and MDM4, termed the cancer spliceome, occurs in response to cellular stress and in cancerous cells.
- This cancer spliceome provides a molecular fingerprint for aberrant cells.
- Cataloging these splice variants aids in understanding cancer development and potential diagnostic markers.
Related Concept Videos
RNA Splicing
RNA Splicing
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
